EE345 Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2-Months Is Cost Effective for the Treatment of HIV-1 in Spain

Saved in:
Bibliographic Details
Published inValue in health Vol. 25; no. 12; p. S122
Main Authors Moreno Guillén, S, Rivero, A, Ventayol, P, Falcó, V, Torralba, M, Schroeder, M, Neches, V, Vallejo-Aparicio, LA, Mackenzie, I, Turner, M, Harrison, C
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.12.2022
Online AccessGet full text

Cover

More Information
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2022.09.591